Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilan Kirsch

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Molecular Cancer Therapeutics|May 2, 2006
Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panelKimberly J Bussey, Koei Chin, Samir Lababidi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2021
Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional TrialMatthew J Frank, Nasheed M Hossain, Ali Bukhari, et al.
Journal for Immunotherapy of Cancer|June 28, 2017
Immunotherapy biomarkers 2016: overcoming the barriersJames L Gulley, Jay A Berzofsky, Marcus O Butler, et al.
Journal for Immunotherapy of Cancer|October 26, 2024
<i>CRLF2</i>-rearranged B-cell ALL with extramedullary lineage switch to AML following CD19-targeted therapySara K Silbert, Samantha Scanlon, Hao-Wei Wang, et al.
JCI Insight|April 19, 2022
Longitudinal analysis of T cell receptor repertoires reveals shared patterns of antigen-specific response to SARS-CoV-2 infectionRachel M Gittelman, Enrico Lavezzo, Thomas M Snyder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 20, 2023
Tumor-Infiltrating Normal B Cells Revealed by Immunoglobulin Repertoire Clonotype Analysis Are Highly Prognostic and Crucial for Antitumor Immune Responses in DLBCLZijun Y Xu-Monette, Yong Li, Thomas Snyder, et al.
Journal for Immunotherapy of Cancer|October 24, 2019
Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapiesZijun Y Xu-Monette, Jianyong Li, Yi Xia, et al.
Journal for Immunotherapy of Cancer|March 17, 2016
Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trialsHolbrook E Kohrt, Paul C Tumeh, Don Benson, et al.
Blood|January 29, 2021
CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR-refractory large B-cell lymphomaJohn H Baird, Matthew J Frank, Juliana Craig, et al.
The New England Journal of Medicine|December 9, 2024
Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in ChildrenSumit Gupta, Rachel E Rau, John A Kairalla, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Molecular Cancer Therapeutics|May 2, 2006
Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panelKimberly J Bussey, Koei Chin, Samir Lababidi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2021
Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional TrialMatthew J Frank, Nasheed M Hossain, Ali Bukhari, et al.
Journal for Immunotherapy of Cancer|June 28, 2017
Immunotherapy biomarkers 2016: overcoming the barriersJames L Gulley, Jay A Berzofsky, Marcus O Butler, et al.
Journal for Immunotherapy of Cancer|October 26, 2024
<i>CRLF2</i>-rearranged B-cell ALL with extramedullary lineage switch to AML following CD19-targeted therapySara K Silbert, Samantha Scanlon, Hao-Wei Wang, et al.
JCI Insight|April 19, 2022
Longitudinal analysis of T cell receptor repertoires reveals shared patterns of antigen-specific response to SARS-CoV-2 infectionRachel M Gittelman, Enrico Lavezzo, Thomas M Snyder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 20, 2023
Tumor-Infiltrating Normal B Cells Revealed by Immunoglobulin Repertoire Clonotype Analysis Are Highly Prognostic and Crucial for Antitumor Immune Responses in DLBCLZijun Y Xu-Monette, Yong Li, Thomas Snyder, et al.
Journal for Immunotherapy of Cancer|October 24, 2019
Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapiesZijun Y Xu-Monette, Jianyong Li, Yi Xia, et al.
Journal for Immunotherapy of Cancer|March 17, 2016
Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trialsHolbrook E Kohrt, Paul C Tumeh, Don Benson, et al.
Blood|January 29, 2021
CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR-refractory large B-cell lymphomaJohn H Baird, Matthew J Frank, Juliana Craig, et al.
The New England Journal of Medicine|December 9, 2024
Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in ChildrenSumit Gupta, Rachel E Rau, John A Kairalla, et al.
Pageof 4